COCP
NASDAQ · Pharmaceuticals
Cocrystal Pharma Inc
$1.38
-0.05 (-3.50%)
Open$1.45
Previous Close$1.43
Day High$1.45
Day Low$1.38
52W High$2.67
52W Low$0.86
Volume—
Avg Volume134.3K
Market Cap19.85M
P/E Ratio—
EPS$-0.79
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+1,923.2% upside
Current
$1.38
$1.38
Target
$27.92
$27.92
$19.61
$27.92 avg
$38.36
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.74M | 2.80M | 3.00M |
| Net Income | 504.5K | 668.5K | 544.9K |
| Profit Margin | 18.4% | 23.9% | 18.1% |
| EBITDA | 921.2K | 997.7K | 969.2K |
| Free Cash Flow | 728.8K | 746.2K | 561.0K |
| Rev Growth | +19.3% | -9.2% | +14.0% |
| Debt/Equity | 0.92 | 0.92 | 0.80 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |